Sabra Healthcare REIT (SBRA) Stock Price, News & Analysis

Company Overview

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.

Founded in 2010, Sabra was established as a healthcare-focused REIT and initially acquired a portfolio of facilities from Sun Healthcare Group. Its shares trade on the Nasdaq under the symbol SBRA.

Key Stats

• Today's Range: $20.22 to $20.48
• 50-Day Range: $18.74 to $21.47
• 52-Week Range: $17.53 to $22.77
• Volume: 2.33 million shs
• Average Volume: 2.69 million shs
• Market Capitalization: $5.35 billion
• P/E Ratio: 73.00
• Dividend Yield: 5.87%
• Price Target: $21.67
• Consensus Rating: Moderate Buy

Sabra Healthcare REIT Stock Analysis - MarketRank™

Sabra Healthcare REIT scored higher than 50% of companies evaluated by MarketBeat, and ranked 129th out of 191 stocks in the real estate sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Sabra Healthcare REIT has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 1 strong buy rating, 7 buy ratings, 6 hold ratings, and no sell ratings.

Upside/Downside

The consensus price target for Sabra Healthcare REIT is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Sabra Healthcare REIT has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 5.26%

Earnings Growth

Earnings for Sabra Healthcare REIT are expected to grow by 5.26% in the coming year, from $1.52 to $1.60 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sabra Healthcare REIT is 72.96, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.42.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sabra Healthcare REIT is 72.96, which means that it is trading at a more expensive P/E ratio than the Real Estate sector average P/E ratio of about 30.46.

Price to Earnings Growth Ratio

Sabra Healthcare REIT has a PEG Ratio of 1.83. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Sabra Healthcare REIT has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.90% of the float of Sabra Healthcare REIT has been sold short.

Short Interest Ratio / Days to Cover

Sabra Healthcare REIT has a short interest ratio ("days to cover") of 8.26.

Change versus previous month

Short interest in Sabra Healthcare REIT has recently increased by 0.93%, indicating that investor sentiment is decreasing.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Leadership

Sabra Healthcare REIT is a leading dividend payer. It pays a dividend yield of 5.72%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Sabra Healthcare REIT does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sabra Healthcare REIT is 428.57%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Sabra Healthcare REIT will have a dividend payout ratio of 75.00% next year. This indicates that Sabra Healthcare REIT will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.26

News Sentiment

Sabra Healthcare REIT has a news sentiment score of 0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Real Estate companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Sabra Healthcare REIT this week, compared to 3 articles on an average week.

Search Interest

8 people have searched for SBRA on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

MarketBeat Follows

6 people have added Sabra Healthcare REIT to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Sabra Healthcare REIT insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,375,800.00 in company stock.

Percentage Held by Insiders

1.09% of the stock of Sabra Healthcare REIT is held by insiders.

Percentage Held by Institutions

99.40% of the stock of Sabra Healthcare REIT is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 8/31 Dividend: 8/14/2026
• Ex-Dividend for 8/31 Dividend: 8/14/2026
• Dividend Payable: 8/31/2026
• Last Earnings: 11/02/2026
• Today: 11/13/2026
• Record date for 11/30 Dividend: 11/13/2026
• Ex-Dividend for 11/30 Dividend: 11/13/2026
• Dividend Payable: 11/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Real Estate
• Industry: Healthcare REITs
• Sub-Industry: Healthcare REITs
• Current Symbol: NASDAQ:SBRA
• CIK: 1492298
• Web: www.sabrahealth.com
• Phone: (888) 393-8248
• Fax: 949-679-8868
• Employees: 58
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Sabra Healthcare REIT: $21.67
• High Price Target: $25.00
• Low Price Target: $19.00
• Potential Upside/Downside: +6.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.64
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.28
• Trailing P/E Ratio: 73.00
• Forward P/E Ratio: 12.78
• P/E Growth: 1.83
• Net Income: $155.61 million
• Net Margins: 7.78%
• Pretax Margin: 7.07%
• Return on Equity: 2.55%
• Return on Assets: 1.30%

Debt

• Debt-to-Equity Ratio: 0.86
• Current Ratio: 1.21
• Quick Ratio: 1.21

Sales & Book Value

• Annual Sales: $774.63 million
• Price / Sales: 6.91
• Cash Flow: $1.34 per share
• Price / Cash Flow: 15.26
• Book Value: $10.85 per share
• Price / Book: 1.88

Miscellaneous

• Outstanding Shares: 261,960,000
• Free Float: 259,106,000
• Market Cap: $5.35 billion
• Optionable: Optionable
• Beta: 0.68